692
695
de Jong, Marit, Oskam, Marieke J., Sep, Simone J. S., Ozcan, Behiye, Rutters, Femke, Sijbrands, Eric J. G., Elders, Petra J. M., Siegelaar, Sarah E., Devries, J. Hans, Tack, Cees J., Schroijen, Marielle, de Valk, Harold W., Abbink, Evertine J., Stehouwer, Coen D. A., Jazet, Ingrid, Wolffenbuttel, Bruce H. R., Peters, Sanne A. E., Schram, Miranda T.
Veröffentlicht in: de Jong , M , Oskam , M J , Sep , S J S , Ozcan , B , Rutters , F , Sijbrands , E J G , Elders , P J M , Siegelaar , S E , Devries , J H , Tack , C J , Schroijen , M , de Valk , H W , Abbink , E J , Stehouwer , C D A , Jazet , I , Wolffenbuttel , B H R , Peters , S A E & Schram , M T 2020 , ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: Findings from the Dutch Diabetes Pearl cohort ' , BMJ Open Diabetes Research and Care , vol. 8 , no. 1 , e001365 . https://doi.org/10.1136/bmjdrc-2020-001365;
2020
Volltext
696
698
de Jong, Marit, Oskam, Marieke J., Sep, Simone J. S., Ozcan, Behiye, Rutters, Femke, Sijbrands, Eric J. G., Elders, Petra J. M., Siegelaar, Sarah E., DeVries, J. Hans, Tack, Cees J., Schroijen, Marielle, de Valk, Harold W., Abbink, Evertine J., Stehouwer, Coen D. A., Jazet, Ingrid, Wolffenbuttel, Bruce H. R., Peters, Sanne A. E., Schram, Miranda T.
Veröffentlicht in: de Jong , M , Oskam , M J , Sep , S J S , Ozcan , B , Rutters , F , Sijbrands , E J G , Elders , P J M , Siegelaar , S E , DeVries , J H , Tack , C J , Schroijen , M , de Valk , H W , Abbink , E J , Stehouwer , C D A , Jazet , I , Wolffenbuttel , B H R , Peters , S A E , Schram , M T & Diabet Pearl Parelsnoer Initiative 2020 , ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes : findings from the Dutch Diabetes Pearl cohort ' , BMJ Open Diabetes Research & Care , vol. 8 , no. 1 , 001365 . https://doi.org/10.1136/bmjdrc-2020-001365;
2020
699
van den Ende, R.P.J., Peters, F.P., Harderwijk, E., Rutten, H., Bouwmans, L., Berbee, M., Canters, R.A.M., Stoian, G., Compagner, K., Rozema, T., de Smet, M., Intven, M.P.W., Tijssen, R.H.N., Theuws, J., van Haaren, P., van Triest, B., Eekhout, D., Marijnen, C.A.M., van der Heide, U.A., Kerkhof, E.M.
Veröffentlicht in: van den Ende , R P J , Peters , F P , Harderwijk , E , Rutten , H , Bouwmans , L , Berbee , M , Canters , R A M , Stoian , G , Compagner , K , Rozema , T , de Smet , M , Intven , M P W , Tijssen , R H N , Theuws , J , van Haaren , P , van Triest , B , Eekhout , D , Marijnen , C A M , van der Heide , U A & Kerkhof , E M 2020 , ' Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results ' , Radiation Oncology , vol. 15 , no. 1 , 41 . https://doi.org/10.1186/s13014-020-01487-6;
2020